Topiramate
Product Images NDC 12634-083

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 12634-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotheca Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (083 71)

Topiramate 100 mg tablet bottle label by Apotheca Inc., NDC 12634-083-71. The label indicates a container of 30 tablets with child-resistant closure, includes lot and expiration date areas, and provides usage directions and safety warnings. Manufactured by San Pharmaceutical Industries Limited, India.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of Topiramate, showing its molecular framework with multiple rings, ether groups, and a sulfamate moiety, consistent with its known active ingredient structure.*

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier curve showing cumulative rates for time to first seizure comparing Topiramate 50 mg/day and 400 mg/day. The Y-axis represents cumulative rates, and the X-axis shows time in days up to 500. Two separate curves illustrate seizure occurrence over time for different dosage groups, with a p-value of 0.0002 indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.